FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)

Aristides Polyzos, Nikolaos Malamos, Ioannis Boukovinas, Adamos Adamou, Nikolaos Ziras, Kostas Kalbakis, Stylianos Kakolyris, Kostas Syrigos, Pavlos Papakotoulas, Charalambos Kouroussis, Nikolaos Karvounis, Lambros Vamvakas, Charalambos Christophyllakis, Athanasios Athanasiadis, Ioannis Varthalitis, Vassilis Georgoulias, Dimitris Mavroudis

Open source

DOI: 10.1007/s10549-009-0468-0
Published: 2009-07-28
Container: Breast Cancer Research and Treatment
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10549-009-0468-0,
  title = {FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)},
  author = {Aristides Polyzos and Nikolaos Malamos and Ioannis Boukovinas and Adamos Adamou and Nikolaos Ziras and Kostas Kalbakis and Stylianos Kakolyris and Kostas Syrigos and Pavlos Papakotoulas and Charalambos Kouroussis and Nikolaos Karvounis and Lambros Vamvakas and Charalambos Christophyllakis and Athanasios Athanasiadis and Ioannis Varthalitis and Vassilis Georgoulias and Dimitris Mavroudis},
  year = {2009},
  journal = {Breast Cancer Research and Treatment},
  doi = {10.1007/s10549-009-0468-0},
  url = {https://doi.org/10.1007/s10549-009-0468-0}
}

RIS

TY  - JOUR
TI  - FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)
AU  - Aristides Polyzos
AU  - Nikolaos Malamos
AU  - Ioannis Boukovinas
AU  - Adamos Adamou
AU  - Nikolaos Ziras
AU  - Kostas Kalbakis
AU  - Stylianos Kakolyris
AU  - Kostas Syrigos
AU  - Pavlos Papakotoulas
AU  - Charalambos Kouroussis
AU  - Nikolaos Karvounis
AU  - Lambros Vamvakas
AU  - Charalambos Christophyllakis
AU  - Athanasios Athanasiadis
AU  - Ioannis Varthalitis
AU  - Vassilis Georgoulias
AU  - Dimitris Mavroudis
PY  - 2009
JO  - Breast Cancer Research and Treatment
DO  - 10.1007/s10549-009-0468-0
UR  - https://doi.org/10.1007/s10549-009-0468-0
ER  -

APA

Polyzos, A., Malamos, N., Boukovinas, I., Adamou, A., Ziras, N., Kalbakis, K., Kakolyris, S., Syrigos, K., Papakotoulas, P., Kouroussis, C., Karvounis, N., Vamvakas, L., Christophyllakis, C., Athanasiadis, A., Varthalitis, I., Georgoulias, V., & Mavroudis, D. (2009). FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG). Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-009-0468-0

Source records

crossref · retrieved 2026-11-11T00:49:28.875Z